HACKENSACK, N.J.--(BUSINESS WIRE)--John Theurer Cancer Center at Hackensack University Medical Center today announced publication of breakthrough data in the treatment of advanced multiple myeloma in the journal Biology of Blood and Marrow Transplantation. Led by Michele L. Donato, MD, and conducted at John Theurer Cancer Center, one of the largest performers of allogeneic transplantation for multiple myeloma in the world, this clinical study demonstrates that allogeneic transplantation for multiple myeloma can lead to sustained remission, even in patients with relapsed refractory diseases, prolonging the lives of trial participants.
“Multiple myeloma is believed to be an incurable disease, even though today’s medicines are able to achieve remission, and sometimes a very durable remission. While the vast majority of patients will ultimately succumb to the disease, it is a belief of mine that allogeneic transplantation has potential to change that reality,” states Andrew L. Pecora, M.D., President of Regional Cancer Care Associates, as well as Chief Innovations Officer and Vice President of Cancer Services at John Theurer Cancer Center.
Help employers find you! Check out all the jobs and post your resume.
